Insulin aspart
Fiasp, Novolog, NovoMix, NovoRapid (insulin aspart) is a protein pharmaceutical. Insulin aspart was first approved as Fiasp on 1999-09-07. It has been approved in Europe to treat diabetes mellitus.
Trade Name | Fiasp, NovoMix, NovoRapid |
---|---|
Common Name | Insulin aspart |
Indication | diabetes mellitus |
Drug Class |
